When it comes to cancer, no two patients are alike. That’s why we’re using advanced techniques for diagnosis and finding precise ways to treat all types of cancer. From activating the immune system to fight cancer, to building a team of cancer experts to tackle the most difficult cases, we’re here to help you every step of the way.
Hard to treat and recurring cancers pose a challenge for clinicians and their patients. To tackle these most difficult cases, Stanford has created a Molecular Tumor Board. This group of oncologists, pathologists and geneticists meets every other week to review the specific mutations identified in patients' cancers.
To accurately select the most beneficial therapy available, the board first conducts a genomic analysis of a patient’s tumor using the Solid Tumor Actionable Mutation Panel (STAMP) developed at Stanford. This next-generation sequencing method targets 130 genes that are known to have actionable mutations that respond to anti-cancer therapies. With this knowledge, the board can prescribe a treatment that specifically targets the mutation found in the patient’s cancer. This individualized approach to cancer treatment is currently available to patients with solid tumors (such as colon, breast and lung cancers) that have not responded to standard treatments.